<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2018</year>
    <pub-dates>
     <date>2020-07-29</date>
    </pub-dates>
   </dates>
   <doi>10.1186/s13287-018-0773-9</doi>
   <abstract>In the past years, cardiac mortality has decreased,&#13;
but cardiac diseases are still responsible for millions&#13;
of deaths every year worldwide. Bone-marrow&#13;
mesenchymal stem cells (BMSCs) transplantation may&#13;
be a promising therapeutic strategy because of its&#13;
capacity to differentiate into cardiac cells. Current&#13;
research indicates that chemical substances,&#13;
microRNAs, and cytokines have biological functions&#13;
that regulate the cardiomyocytes differentiation of&#13;
BMSCs. In this review, we chiefly summarize the&#13;
regulatory factors that induce BMSCs to differentiate&#13;
into cardiomyocytes.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/132</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/132</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
